Zika N-Terminal Envelope Protein


Catalog Number: B2012329 (100 ug)
Zika N-Terminal Envelope Protein is a high quality recombinant Zika N-Terminal Envelope Protein. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.

Live enquiry about this product via Text/SMS: 1-858-900-3210.

In stock

SKU: B2012329 Categories: , Tag:


Zika N-Terminal Envelope Protein
Catalog number: B2012329
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: na
Supplied as: Solution
Applications: molecular tool for various biochemical applications
Storage: -20°C
Keywords: Zika Envelope N protein
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

1: Giraldo MI, Xia H, Aguilera-Aguirre L, Hage A, van Tol S, Shan C, Xie X, Sturdevant GL, Robertson SJ, McNally KL, Meade-White K, Azar SR, Rossi SL, Maury W, Woodson M, Ramage H, Johnson JR, Krogan NJ, Morais MC, Best SM, Shi PY, Rajsbaum R. Envelope protein ubiquitination drives entry and pathogenesis of Zika virus Nature. 2020 Sep;585(7825):414-419.
2: Dai L, Wang Q, Song H, Gao GF. Zika Virus Envelope Protein and Antibody Complexes Subcell Biochem. 2018;88:147-168.
3: Elfiky AA, Ibrahim IM. Zika virus envelope – heat shock protein A5 (GRP78) binding site prediction J Biomol Struct Dyn. 2021 Sep;39(14):5248-5260.
4: Yang C, Gong R, de Val N. Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure Virol Sin. 2019 Apr;34(2):168-174.
5: Carbaugh DL, Baric RS, Lazear HM. Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis J Virol. 2019 May 29;93(12):e00113-19.
6: Wang Y, Li Q, Hu D, Gao D, Wang W, Wu K, Wu J. USP38 Inhibits Zika Virus Infection by Removing Envelope Protein Ubiquitination Viruses. 2021 Oct 8;13(10):2029.
7: Hu D, Wang Y, Li A, Li Q, Wu C, Shereen MA, Huang S, Wu K, Zhu Y, Wang W, Wu J. LAMR1 restricts Zika virus infection by attenuating the envelope protein ubiquitination Virulence. 2021 Dec;12(1):1795-1807.
8: Gunawardana SA, Shaw RH. Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora’s box? BMC Infect Dis. 2018 Dec 10;18(1):641.
9: Pindi C, Chirasani VR, Senapati S. Identifying crucial E-protein residues responsible for unusual stability of Zika virus envelope Biophys J. 2021 Sep 21;120(18):4041-4054.
10: Kim YC, Nettleship JE, García-Larragoiti N, Mar MA, Mondragón-García AL, Ríos-Valencia J, Figueroa-Aguilar G, Viveros-Sandoval ME, Owens RJ, Reyes-Sandoval A. Temperature-dependent secretion of Zika virus envelope and non-structural protein 1 in mammalian cells for clinical applications J Virol Methods. 2021 Aug;294:114175.

Products Related to Zika N-Terminal Envelope Protein can be found at Proteins

How to Order

1- Order online using our website’s automated shopping cart and checkout system (available 24/7).

2- Order by email: (we accept electronic PO, available 24/7).

3- Order by Fax: 1-858-437-9884 (available 24/7).

4- Order by phone: 1-858-900-3210 (6 am – 8 pm PST).

5- Order by Text/SMS: 1-858-900-3210 (6 am – 8 pm PST).